Skip to content

Evaluation of anesthetic effect of Esketamine combined with propofol in patients undergoing gastrointestinal endoscopes

Evaluation of anesthetic effect of Esketamine combined with propofol in patients undergoing gastrointestinal endoscopes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066222
Enrollment
Unknown
Registered
2022-11-28
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Diseases

Interventions

experimental group:Propofol combined with Esketamine

Sponsors

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing painless gastroenteroscopy 2. Age: >=18 years old 3. ASA classification: I-III 4. BMI value: 18 ~ 30kg/m2

Exclusion criteria

Exclusion criteria: 1. Patients with heart disease, severe hypertension and hyperthyroidism 2. Patients with mental or nervous system diseases 3. Patients with severe liver and kidney insufficiency 4. Severe hearing or visual impairment, unable to cooperate with patients 5. Patients with contraindications to drugs 6. Patients with drug allergies

Design outcomes

Primary

MeasureTime frame
Vital signs indicators;

Secondary

MeasureTime frame
Incidence of intraoperative body movement;Patient recovery time;Patient Steward recovery score;Patients' satisfaction degree;Postoperative delirium score;Incidence of postoperative nausea and vomiting;

Countries

China

Contacts

Public ContactTang Dongliang

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School

408570117@qq.com15150759366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026